| URL | https://www.pharmamanufacturing.com/industrynews/2 |
| Source | Pharma Manufacturing |
| Date Published | 05/12/2021 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Avantor |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2021 |
| Domestically, the work will be done: | In-house |
| State(s) reshored to: | NC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | single use technologies (pharma) |
| What domestic positive factors made reshoring more attractive? | , covid-19 |